RXRX Today - Aug 12: Short Interest Rises

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

RXRX Today - Aug 12: Short Interest Rises

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your go-to guy for stock chat. I’ve been in the investing game for a while now, and today we're talking about Recursion, ticker RXRX. Spoiler alert: it was a red day for them, down about 1.6%.

So, what happened? Recursion got smoked today. The stock took a hit, and it seems like traders were feeling pretty nervous. There was a lot of chatter about short interest rising to over 35%. That’s a big deal! When more people are betting against a stock, it can really shake things up. Plus, I saw some reports about folks buying up put options, which kinda signals that people were expecting more downside. Not a great vibe for the bulls.

Now, why did this happen? Well, it looks like there’s some concern about Recursion's growth. They’ve been pushing hard on their AI drug discovery partnerships, but even with that, they’re facing a cash burn and slow growth. That can freak investors out. Plus, there was some bearish sentiment floating around in the air, especially after a recent article pointed out that even with the Genentech news, there’s still a lot of skepticism about Recursion's future. Yeah, that one stung.

On the horizon, there’s a notice of proposed sale of securities under Rule 144. That could mean they’re looking to raise some cash, which is worth keeping an eye on. It’s like, more dilution might be coming down the line, and nobody loves that.

So, to wrap it up, Recursion had a tough day with a lot of noise about short selling and concerns over their growth strategy. It’s a wild ride in the biotech space, and RXRX is right in the middle of it. Just remember, this is all for fun and info—no financial advice here. Catch you later!

まだレビューはありません